Amdocs had cash and cash equivalents of $1.19 billion as of Jun, 2020, up from $763 million on Mar 31, 2020. Cash flow from operating activities was $186.7 million, up from $103 million recorded in the previous quarter and $164.5 million in the year-ago quarter. Free cash flow was $145.4 million compared with previous quarter's $57 million and $128.6 million reported in the year-ago quarter. During the fiscal third quarter, the company repurchased shares worth $60 million. Amdocs' board of directors approved the payment of a quarterly dividend of $0.3275 per share.